Jul 26, 2018 by Brian Orelli, PhDBaby Steps: Natus Medical Hits Its ExpectationsAfter its recent turmoil, investors will take it.
Jul 25, 2018 by Brian Orelli, PhDBiogen Posts Solid Earnings as the Biotech Waits for Clinical Trial DataLooking for the next Spinraza.
Jul 25, 2018 by Brian Orelli, PhDHere's Why Natus Medical Stock Jumped TodayIt seems investors are excited by the lack of bad news.
Jul 24, 2018 by Brian Orelli, PhDHere's Why bluebird bio, Inc. Is Down TodayThe biotech keeps feeding its coffers.
Jul 23, 2018 by Brian Orelli, PhDHere's Why AVEO Pharmaceuticals Inc. Jumped TodayInvestors are buying into the company's explanation for a delay in clinical trial data.
Jul 18, 2018 by Brian Orelli, PhDHere's Why Healthcare Services Group Stock Plummeted TodaySlowing growth at the hospital outsourcing company has investors nervous.
Jul 17, 2018 by Brian Orelli, PhDHere's Why AVEO Pharmaceuticals Inc. Plummeted Today Without Issuing a Press ReleaseSometimes you've got to dig into SEC documents to find the answer.
Jul 13, 2018 by Brian Orelli, PhDHere's Why Galmed Pharmaceuticals Ltd. Was Up 19% Today and 33% for the WeekAnalysts love this biotech, but should you?
Jul 13, 2018 by Brian Orelli, PhDHere's Why Marijuana Stock Insys Therapeutics Rose 11% in JuneIt's a non-marijuana-based drug that has investors excited this time.
Jul 13, 2018 by Brian Orelli, PhDHere's Why ImmunoGen Fell 15.1% in JuneA secondary offering dilutes investors.
Jul 13, 2018 by Brian Orelli, PhDHere's Why Puma Biotechnology Rose 11.7% in JuneThe biotech had a reverse of fortune for its lead drug in Europe
Jul 13, 2018 by Brian Orelli, PhDHere's Why Marijuana and Tobacco Stock 22nd Century Group Rose 16% in JuneETFs and mutual funds are adding the company. Should you?
Jul 13, 2018 by Brian Orelli, PhDHere's Why Marijuana Stock GW Pharmaceuticals Fell 13.3% in JuneInvestors learn that not every FDA drug approval creates a stock pop.
Jul 12, 2018 by Brian Orelli, PhDWhy OPKO Health Jumped 21.1% in JuneInvestors are feeling more comfortable with the potential of the company's drugs and diagnostic tests.
Jun 27, 2018 by Brian Orelli, PhDWhy Sangamo Therapeutics and bluebird bio Slipped Lower TodayData from a competitor puts pressure on both biotechs' sickle cell programs
Jun 27, 2018 by Brian Orelli, PhDHere's Why Drug Developer DURECT Corporation Plunged TodayRemoxy is the gift that keeps on giving (and not in a good way).
Jun 21, 2018 by Brian Orelli, PhDHere's Why Patterson Companies Jumped Higher TodayThe dental and animal health company managed to meet its lowered expectations.
Jun 19, 2018 by Brian Orelli, PhDWhy PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% YesterdayWelcome to biotech investing.
Jun 18, 2018 by Brian Orelli, PhDHere's Why PTC Therapeutics Is Soaring While Biogen and Ionis StruggleInvestors value a new round of data for PTC's spinal muscular atrophy drug.
